Case of the month by Moylan, Kyle
(cont) elevated troponins than did those patients whose statin therapy was discontinued for at least four days 
postoperatively. 
In conclusion, the data thus far strongly suggests that perioperative statin therapy is beneficial in patients un-
dergoing noncardiac surgery.  Unfortunately, due to a lack of randomized trials, the evidence is far from de-
finitive; nevertheless, the early evidence is compelling and may already be able to guide therapy in two areas.  
First, discontinuing statins perioperatively likely increases the rate of adverse cardiac events; second, starting 
statins at least four weeks prior to noncardiac surgery seems to provide cardiovascular benefit for patients 
who are at increased cardiac risk.  More robust data is expected in the near future and, hopefully, will give 
hospitalists another management resource for their perioperative toolkit. 
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CASE OF THE MONTH      Kyle Moylan MD 
Orthopedic Surgery requested an inpatient Internal Medicine consultation for evaluation of an 81 year old 
woman with multiple vertebral fractures of possible pathologic origin.  The patient had been in excellent 
health with no chronic medical problems and took no medications.  Three months prior to admission, she pre-
sented to an outside ER with the acute onset of midline thoracic back pain that started immediately after lifting 
a gallon of milk.  The pain was severe but she had no associated neurologic symptoms.  A plain radiograph 
revealed a vertebral compression fracture (level not specified); no labs were obtained and she was sent home 
with analgesics and a referral to orthopedic clinic in one month.  At that visit, she was prescribed Tylenol and 
offered vertebroplasty but the patient declined.  She presented to the University Hospital ER one month later 
with worsening pain, uncontrolled by the Tylenol; a plain radiograph revealed severe T-6 and L-4 vertebral 
compression fractures; these were not present on films obtained one month prior.  A T-11 anterior wedge de-
formity, presumably the original fracture, was unchanged.  The patient was seen by Orthopedic Surgery in the 
ER; she was prescribed cyclobenzaprine, ibuprofen and a Jewett brace and was set up for an outpatient MRI 
and an orthopedic spine surgery appointment.  There was some discussion of an inpatient evaluation but the 
patient had declined.  With this management, the mid thoracic pain improved but she experienced worsening 
pain in the upper lumbar and thoracolumbar area.          (continued on page 3) 
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Rise  The MRI of the thoracic and lumbar spine was performed two weeks prior to admission.  This revealed multi-
ple zones of abnormal vertebral body signal, most prominent at T6, T11, L4 and in the sacrum.  Additional 
innumerable punctuate zones of signal abnormality were also found throughout the vertebrae.  There was no 
compression of the neural canal.  These findings were interpreted as highly suggestive of metastatic disease 
and she was seen at the Spine Center later that day.  Since malignancy was suspected, an outpatient bone scan 
was performed that demonstrated abnormal uptake in the bodies of L3 and T10 and in the posterior elements 
of T6.  Abnormal foci were also seen in the right lateral 6th and 9th ribs and in the left 7th rib.  A CT scan of 
the chest, abdomen and pelvis showed no evidence of a primary malignancy or of other metastases. 
One week prior to admission, a vertebroplasty and biopsy was performed successfully at the T-11 vertebra; 
the biopsy was negative, consisting mostly of blood.  On follow-up, the patient reported increasing pain and 
repeat radiography showed a new T12  anterior wedge deformity, consistent with an acute fracture.  She was 
admitted for a T12 vertebroplasty and repeat biopsy attempt. 
During this admission, Internal Medicine was consulted.  The patient denied additional symptoms except for 
some anorexia and an unintentional 15 pound weight loss over the past year.  She was taking Calcium 600mg 
+Vitamin D TID, ibuprofen 600 mg TID and prn cyclobenzaprine.  She denied trauma, falls, lymphadenopa-
thy, fever, night sweats, chills or breast mass.  Physical findings were limited to tenderness over the thoraco-
lumbar area; there were no neurological deficits and breast, rectal and lymph node exams were normal.  Labs 
were remarkable for Hgb 11.0, MCV 90, WBC 12.1 (normal diff), BUN 23, Cr 1.4, Ca 12.0; LFTs, including AP, 
TP and Alb were normal.  ESR was 39mm/hr and CRP was high at 1.3 mg/dl.  Serum and urine protein electro-
phoresis had been performed and were normal. 
Based on the patient’s age, lack of primary tumor, hypercalcemia, anemia and renal dysfunction, the working 
diagnosis was multiple myeloma.  Zoledronic acid 4mg IV was given for the hypercalcemia and the serum 
calcium normalized within 48 hrs.  Her renal function improved (Cr 1.1 on discharge) and her pain was con-
trolled with scheduled Tylenol 1000 TID and prn oxycodone; her appetite improved and she was ambulating 
in the halls prior to discharge. 
Additional labs included serum beta-2 microglobulin 3.9 mg/L (normal 1.1-2.4), 24 hour urine for electropho-
resis and immunofixation with 27.20 mg/dl of kappa light chains (normal .14-2.42) and a kappa:lambda ratio 
of 104.6 (normal 2-10).  A skeletal survey showed no additional lytic lesions and the repeat biopsy confirmed 
multiple myeloma (monotonous sheets of mature plasma cells).  Follow-up was arranged with Heme-Onc. 
Discussion:  Vertebral fractures are common in older patients and are usually due to osteoporosis.  However, 
the physician should look for secondary causes and workup should include serum Ca and Phos, serum intact 
parathyroid hormone, serum 25-hydroxyvitamin D level and protein electrophoresis of serum and urine.  As 
in this patient, multiple myeloma usually occurs in older patients (it is rare under 40) and common clinical 
features include anemia, elevated ESR, proteinuria, marrow failure, infection and renal impairment; other fea-
tures may include hypercalcemia, hyperviscosity, neuropathy, amyloidosis and coagulopathy. 
The primary pathology of multiple myeloma is a neoplastic transformation of a monoclonal plasma cell popu-
lation which produce a monoclonal protein; intact immunoglobulin is most common (IgG 60%, IgA 20%).  
However, some patients, such as ours, have no detectable immunoglobulin by serum and urine electrophore-
sis and immunofixation; these cases represent nonsecretory myeloma or light chain disease. When clinical sus-
picion is high, a 24 hour urine collection is required to detect free light chains (Bence-Jones protein), which 
may be missed by spot urine testing.  Serum beta-2 microglobulin is a new test that adds to our diagnostic ar-
senal and has prognostic significance.  Ultimately, the diagnosis must be confirmed by bone marrow biopsy 
and aspiration. Zoledronic acid is effective at normalizing serum calcium and preventing additional fractures.    
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